New Herpes Virus Monoclonal Antibodies

ViroStat has just released new Monoclonal Antibodies to HSV glycoproteins D and G

Written byViroStat
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

ViroStat has just released new Monoclonal Antibodies to HSV glycoproteins D and GHerpes simplex viruses (HSV) types 1 & 2 cause both oral and genital infections. The resulting skin blisters are painful and can last two or more weeks before healing. These viruses lay dormant in nerve cells and can reactivate causing a return of blisters. Infection lasts a lifetime and currently there is no cure.

The viruses produce a number of diagnostically significant antigens including glycoproteins D and G.

ViroStat has just released new Monoclonal Antibodies to HSV glycoproteins D and G. These are useful tools for developing rapid assays to detect these viral antigens. Go to the ViroStat website, www.virostat-inc.com to download the data sheets of these new antibodies.

Lab manager academy logo

Lab Management Certificate

The Lab Management certificate is more than training—it’s a professional advantage.

Gain critical skills and IACET-approved CEUs that make a measurable difference.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV, & Strep A for use in rapid lateral flow devices as well as antibodies to foodborne pathogens and toxins. Also, many specificities to HCV, HBV, CMV, & EBV for use in anti-viral HTS assays

ViroStat, Inc.
PO Box 8522
Portland, ME 04104 USA

Phone: 207-856-6620
Fax: 207-856-6864
E-mail: info@virostat-inc.com
Web: www.virostat-inc.com

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - May/June 2025

The Benefits, Business Case, And Planning Strategies Behind Lab Digitalization

Joining Processes And Software For a Streamlined, Quality-First Laboratory

Lab Manager May/June 2025 Cover Image